Home LiteratureArticle Details
PMID: 22798321 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

American journal of respiratory and critical care medicine ·Vol. 186 ·No. 6 ·2012-09-15 ·Pages 536-45

Charlson ES, Diamond JM, Bittinger K, Fitzgerald AS, Yadav A, Haas AR, Bushman FD, Collman RG

Abstract

Long-term survival after lung transplantation is limited by infectious complications and by bronchiolitis obliterans syndrome (BOS), a form of chronic rejection linked in part to microbial triggers. To define microbial populations in the respiratory tract of transplant patients comprehensively using unbiased high-density sequencing. Lung was sampled by bronchoalveolar lavage (BAL) and upper respiratory tract by oropharyngeal wash (OW). Bacterial 16S rDNA and fungal internal transcribed spacer sequencing was used to profile organisms present. Outlier analysis plots defining taxa enriched in lung relative to OW were used to identify bacteria enriched in lung against a background of oropharyngeal carryover. Lung transplant recipients had higher bacterial burden in BAL than control subjects, frequent appearance of dominant organisms, greater distance between communities in BAL and OW indicating more distinct populations, and decreased respiratory tract microbial richness and diversity. Fungal populations were typically dominated by Candida in both sites or by Aspergillus in BAL but not OW. 16S outlier analysis identified lung-enriched taxa indicating bacteria replicating in the lower respiratory tract. In some cases this confirmed respiratory cultures but in others revealed enrichment by anaerobic organisms or mixed outgrowth of upper respiratory flora and provided quantitative data on relative abundances of bacteria found by culture. Respiratory tract microbial communities in lung transplant recipients differ in structure and composition from healthy subjects. Outlier analysis can identify specific bacteria replicating in lung. These findings provide novel approaches to address the relationship between microbial communities and transplant outcome and aid in assessing lung infections.

MeSH Terms
Adult Bronchiolitis Obliterans/microbiology,physiopathology Bronchoalveolar Lavage Fluid/microbiology Bronchoscopy/methods Candidiasis, Invasive/epidemiology,physiopathology Case-Control Studies DNA, Bacterial/analysis,genetics DNA, Fungal/analysis,genetics Female Follow-Up Studies Graft Rejection/epidemiology,microbiology Gram-Negative Bacterial Infections/microbiology,physiopathology Gram-Positive Bacterial Infections/microbiology,physiopathology Humans Incidence Invasive Pulmonary Aspergillosis/epidemiology,physiopathology Likelihood Functions Lung Transplantation/adverse effects,methods Male Metagenome Middle Aged Monte Carlo Method Postoperative Complications/microbiology,physiopathology Respiratory Tract Infections/microbiology,physiopathology Risk Assessment Sampling Studies Statistics, Nonparametric
Chemicals
DNA, Bacterial DNA, Fungal
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Charlson Emily S
Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Diamond Joshua M
Bittinger Kyle
Fitzgerald Ayannah S
Yadav Anjana
Haas Andrew R
Bushman Frederic D
Collman Ronald G
References (45)
45 references, click to expand
  1. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.
    Transplantation. 2008 Mar 15;85(5):771-4 PMID: 18337673
  2. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals.
    PLoS Pathog. 2010 Jan 08;6(1):e1000713 PMID: 20072605
  3. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    J Thorac Cardiovasc Surg. 2005 May;129(5):1144-52 PMID: 15867792
  4. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
    Transplantation. 2008 Dec 27;86(12):1857-63 PMID: 19104434
  5. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation.
    J Heart Lung Transplant. 2010 Jun;29(6):665-71 PMID: 20227302
  6. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx.
    mBio. 2010 Jun 22;1(3): PMID: 20802827
  7. Topographical continuity of bacterial populations in the healthy human respiratory tract.
    Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63 PMID: 21680950
  8. Infections in lung allograft recipients: ganciclovir era.
    J Heart Lung Transplant. 2008 May;27(5):528-35 PMID: 18442719
  9. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
    Am J Respir Crit Care Med. 2003 Jul 1;168(1):121-5 PMID: 12672648
  10. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.
    Am J Transplant. 2009 Aug;9(8):1903-11 PMID: 19459819
  11. Disordered microbial communities in the upper respiratory tract of cigarette smokers.
    PLoS One. 2010 Dec 20;5(12):e15216 PMID: 21188149
  12. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.
    Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20529-33 PMID: 18077362
  13. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
    PLoS One. 2011 Feb 22;6(2):e16384 PMID: 21364979
  14. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010.
    J Heart Lung Transplant. 2010 Oct;29(10):1104-18 PMID: 20870165
  15. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.
    Mucosal Immunol. 2010 Mar;3(2):148-58 PMID: 19940845
  16. Should fiberoptic bronchoscopy aspirates be cultured?
    Am Rev Respir Dis. 1976 Jul;114(1):73-8 PMID: 7173
  17. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
    J Heart Lung Transplant. 2010 May;29(5):531-7 PMID: 20133163
  18. Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity.
    J Heart Lung Transplant. 2007 Nov;26(11):1144-8 PMID: 18022080
  19. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.
    Eur Respir J. 2011 Jan;37(1):164-72 PMID: 20562124
  20. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons.
    Genome Res. 2011 Mar;21(3):494-504 PMID: 21212162
  21. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    J Heart Lung Transplant. 1998 Dec;17(12):1255-63 PMID: 9883768
  22. Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery.
    J Clin Microbiol. 2004 Dec;42(12):5940-3 PMID: 15583348
  23. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.
    J Heart Lung Transplant. 2011 Oct;30(10):1104-22 PMID: 21962018
  24. Characterization of some strains from human clinical sources which resemble "Leptotrichia sanguinegens": description of Sneathia sanguinegens sp. nov., gen. nov.
    Syst Appl Microbiol. 2001 Nov;24(3):358-61 PMID: 11822670
  25. Innate immunity influences long-term outcomes after human lung transplant.
    Am J Respir Crit Care Med. 2005 Apr 1;171(7):780-5 PMID: 15640363
  26. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group.
    Chest. 1993 Jan;103(1):59-63 PMID: 8380268
  27. The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients.
    Am Rev Respir Dis. 1989 Jul;140(1):58-61 PMID: 2502056
  28. Vaginal microbiome of reproductive-age women.
    Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7 PMID: 20534435
  29. Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation.
    Transplantation. 2005 Feb 15;79(3):269-75 PMID: 15699755
  30. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.
    PLoS One. 2010 Jun 23;5(6):e11044 PMID: 20585638
  31. Targeting allograft injury and inflammation in the management of post-lung transplant bronchiolitis obliterans syndrome.
    Am J Transplant. 2009 Jun;9(6):1272-8 PMID: 19459806
  32. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Environ Microbiol. 2010 May;12(5):1293-303 PMID: 20192960
  33. Estimating F-statistics.
    Annu Rev Genet. 2002;36:721-50 PMID: 12359738
  34. Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa.
    J Clin Microbiol. 2007 Jun;45(6):1954-62 PMID: 17409203
  35. UniFrac: a new phylogenetic method for comparing microbial communities.
    Appl Environ Microbiol. 2005 Dec;71(12):8228-35 PMID: 16332807
  36. Bacterial community variation in human body habitats across space and time.
    Science. 2009 Dec 18;326(5960):1694-7 PMID: 19892944
  37. FastTree 2--approximately maximum-likelihood trees for large alignments.
    PLoS One. 2010 Mar 10;5(3):e9490 PMID: 20224823
  38. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14.
    Am J Transplant. 2007 Mar;7(3):693-9 PMID: 17217435
  39. Lung transplantation: infection, inflammation, and the microbiome.
    Semin Immunopathol. 2011 Mar;33(2):135-56 PMID: 21271250
  40. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.
    Am J Respir Crit Care Med. 2004 Jul 15;170(2):181-7 PMID: 15130908
  41. Disordered microbial communities in asthmatic airways.
    PLoS One. 2010 Jan 05;5(1):e8578 PMID: 20052417
  42. Patterns of mycobacterium avium culture and PCR positivity in immunodeficient HIV-infected patients: progression from localized to systematic disease, German Aids Study Group (GASG/IDKF).
    Scand J Infect Dis. 1997;29(6):579-84 PMID: 9571738
  43. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis.
    BMC Genomics. 2010 Sep 07;11:488 PMID: 20819230
  44. Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities.
    Appl Environ Microbiol. 2007 Mar;73(5):1576-85 PMID: 17220268
  45. QIIME allows analysis of high-throughput community sequencing data.
    Nat Methods. 2010 May;7(5):335-6 PMID: 20383131
Article Info
Journal
American journal of respiratory and critical care medicine
Abbr.
Am J Respir Crit Care Med
ISSN
1535-4970
Published
2012-09-15
Epub
2012-00-12
Pages
536-45
Language
English
Region
United States
NLM ID
9421642
PMCID
PMC3480531
Subset
IM
Grants
NIAID NIH HHS · P30-AI045008 · United States
NHLBI NIH HHS · K12 HL090021 · United States
NIAID NIH HHS · P30 AI045008 · United States
NIAID NIH HHS · T32 AI060516 · United States
NHLBI NIH HHS · U01 HL098957 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com